Between December 8 and December 10, 2025, SNY faced a series of analyst rating adjustments that tempered investor sentiment.
Nirsevimab is recommended for preventing RSV lower respiratory tract infection in infants younger than one year in their ...
Northwell Health reports pediatricians emphasize vaccines' effectiveness and safety, urging parents to follow the recommended ...
KUALA LUMPUR, Dec 16 — Sanofi and AstraZeneca’s Beyfortus (Nirsevimab) is now approved by the National Pharmaceutical ...
Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.
Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.
U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.
The US Food and Drug Administration (FDA) plans to add a “black box” warning to COVID-19 vaccines, CNN reported, citing two people familiar with the decision. A boxed warning—the FDA’s most serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results